# TULIP ReTrain Study

> **NCT06974539** · NA · NOT_YET_RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 212 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Multiparametric ultrasound with contrast (Sonovue and Optison)

## Key facts

- **NCT ID:** NCT06974539
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06974539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06974539, "TULIP ReTrain Study". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT06974539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*